Surgery for glioma appears to improve complex attention, memory, learning and language, according to a recent Singapore meta-analysis. On the other hand, the procedure seems to result in a slight decline in executive function.
The anti-PD-1 immunotherapy pembrolizumab confers survival benefit over standard chemotherapy in patients with recurrent or metastatic head and neck cancer in the first-line setting, reveals the topline results of the KEYNOTE-048* study presented at ESMO 2018.
Recently, pharmaceutical company Astellas Pharma US announced the three C3 Prize Category Winners of 2018. This initiative was developed to recognize the most winning ideas that have the potential to transform the global patient community. MIMS had the opportunity to engage Ebele Mbanugo, the Grand Prize winner in the Educational Tools category to learn a little about herself and about her prize-winning idea.
Cancer of the corpus uteri (uterine cancer) accounted for nearly 7 percent of all female cancers in Singapore between 2011 and 2015 and was the fourth most frequent female cancer among all Singaporeans.The majority of patients are diagnosed with cancer confined to the uterus and have a 5-year survival rate exceeding 90 percent, while the survival rate of stage IV endometrial cancer is approximately 20 percent. This highlights the importance of recognizing and detecting endometrial cancers early in the natural history.
There is only a slight improvement in prostate cancer detection rate and Gleason grading as a result of obtaining more than one biopsy core per magnetic resonance imaging (MRI) lesion, a study has shown.
Adopting an aggressive prostate biopsy strategy is recommended in men <50 years with prostate-specific antigen ≥1.5 ng/ml, suggests a study. On the other hand, patients with prostate-specific antigen <1.5 ng/ml are not likely to have significant cancer.
New drug applications approved by US FDA as of 01 - 15 November 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Cancer cells hijack the cellular programmes that normally get activated during wound repair and keep them activated permanently to drive and sustain malignancy, making cancer akin to a wound that never heals, says an expert at the recent Frontiers in Cancer Science 2018.
Teenagers and young adults living with perinatally acquired HIV (PaHIV) have a higher risk of developing malignancies and a higher all-cause mortality rate than their non-HIV-infected peers, according to a study from the UK.